ViraferonPeg 2b 150 mcg / 0.5 ml 150 mcg ampoule
Powder and solvent for solution for injection
Compare
|
EU/1/00/132/048
Authorised: 06/02/2002
Schering Plough Europe
|
SPC
PIL
IPAR
|
ViraferonPeg 2b 150mcg / 0.5 ml 150 mcg ampoule
Powder and solvent for solution for injection
Compare
|
EU/1/00/132/049
Authorised: 06/02/2002
Schering Plough Europe
|
SPC
PIL
IPAR
|
ViraferonPeg 2b 80 mcg / 0.5 ml 80 mcg ampoule
Powder and solvent for solution for injection
Compare
|
EU/1/00/132/037
Authorised: 06/02/2002
Schering Plough Europe
|
SPC
PIL
IPAR
|
ViraferonPeg 2b 80mcg / 0.5ml 80 mcg ampoule
Powder and solvent for solution for injection
Compare
|
EU/1/00/132/038
Authorised: 06/02/2002
Schering Plough Europe
|
SPC
PIL
IPAR
|
ViraferonPeg0.5ml 100mcg ampoule
Powder and solvent for suspension for injection
Compare
|
EU/1/00/132/041
Authorised: 06/02/2002
Schering Plough Europe
|
SPC
PIL
IPAR
|
Viralief 50 mg/g Cream
Cream
Compare
|
PA0126/201/001
Authorised: 27/11/1998
Clonmel Healthcare Ltd
|
SPC
PIL
|
Viramune
Tablet
Compare
|
EU/1/97/055/001
Authorised: 05/02/1998
Boehringer Ingelheim International GmbH
|
SPC
PIL
IPAR
|
VIRAMUNE
Oral suspension
Compare
|
EU/1/97/055/002
Authorised: 18/06/1999
Boehringer Ingelheim International GmbH
|
SPC
PIL
IPAR
|
Viramune
Prolonged-release tablet
Compare
|
EU/1/97/055/006
Authorised: 16/09/2011
Boehringer Ingelheim International GmbH
|
SPC
PIL
IPAR
|
Viramune
Prolonged-release tablet
Compare
|
EU/1/97/055/007-009
Authorised: 16/09/2011
Boehringer Ingelheim International GmbH
|
SPC
PIL
IPAR
|
VIREAD
Film-coated tablet
Compare
|
EU/1/01/200/001-002
Gilead Sciences International
|
SPC
PIL
IPAR
|
Viread
Granules
Compare
|
EU/1/01/200/003
Authorised: 22/11/2012
Gilead Sciences International
|
SPC
PIL
IPAR
|
Viread
Film-coated tablet
Compare
|
EU/1/01/200/004-005
Authorised: 22/11/2012
Gilead Sciences International
|
SPC
PIL
IPAR
|
Viread
Film-coated tablet
Compare
|
EU/1/01/200/006-007
Authorised: 22/11/2012
Gilead Sciences International
|
SPC
PIL
IPAR
|
Viread
Film-coated tablet
Compare
|
EU/1/01/200/008-009
Authorised: 22/11/2012
Gilead Sciences International
|
SPC
PIL
IPAR
|
Viscolex Syrup 250 mg / 5 ml Oral Solution
Oral solution
Compare
|
PA0281/070/001
Authorised: 15/10/1986
Pinewood Laboratories Ltd
|
SPC
PIL
|
VISIPAQUE 270 mg I/ml Solution for Injection, glass container
Solution for injection
Compare
|
PA0735/009/003
Authorised: 19/09/1995
GE Healthcare AS
|
SPC
PIL
|
VISIPAQUE 270 mg I/ml Solution for Injection, polypropylene container
Solution for injection
Compare
|
PA0735/009/012
Authorised: 19/09/1995
GE Healthcare AS
|
SPC
PIL
|
VISIPAQUE 320 mg I/ml Solution for Injection, glass container
Solution for injection
Compare
|
PA0735/009/007
Authorised: 19/09/1995
GE Healthcare AS
|
SPC
PIL
|
Visipaque 320 mg I/ml Solution for Injection, polypropylene container
Solution for injection
Compare
|
PA0735/009/013
Authorised: 19/09/1995
GE Healthcare AS
|
SPC
PIL
|